Madrigal Pharmaceuticals Inc (MDGL)
204.65
-13.73
(-6.29%)
USD |
NASDAQ |
Apr 24, 16:00
204.69
+0.04
(+0.02%)
After-Hours: 20:00
Madrigal Pharmaceuticals Total Return Price: 204.65 for April 24, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
April 24, 2024 | 204.65 |
April 23, 2024 | 218.38 |
April 22, 2024 | 213.49 |
April 19, 2024 | 212.04 |
April 18, 2024 | 222.26 |
April 17, 2024 | 228.34 |
April 16, 2024 | 232.98 |
April 15, 2024 | 231.37 |
April 12, 2024 | 236.59 |
April 11, 2024 | 245.27 |
April 10, 2024 | 244.67 |
April 09, 2024 | 249.34 |
April 08, 2024 | 248.64 |
April 05, 2024 | 243.04 |
April 04, 2024 | 241.46 |
April 03, 2024 | 245.23 |
April 02, 2024 | 244.50 |
April 01, 2024 | 255.74 |
March 28, 2024 | 267.04 |
March 27, 2024 | 258.81 |
March 26, 2024 | 247.62 |
March 25, 2024 | 247.62 |
March 22, 2024 | 248.20 |
March 21, 2024 | 255.27 |
March 20, 2024 | 258.99 |
Date | Value |
---|---|
March 19, 2024 | 265.68 |
March 18, 2024 | 283.23 |
March 15, 2024 | 270.37 |
March 14, 2024 | 243.57 |
March 13, 2024 | 272.98 |
March 12, 2024 | 262.67 |
March 11, 2024 | 260.15 |
March 08, 2024 | 255.32 |
March 07, 2024 | 251.03 |
March 06, 2024 | 257.38 |
March 05, 2024 | 248.49 |
March 04, 2024 | 246.56 |
March 01, 2024 | 251.63 |
February 29, 2024 | 236.20 |
February 28, 2024 | 254.23 |
February 27, 2024 | 239.80 |
February 26, 2024 | 232.57 |
February 23, 2024 | 236.54 |
February 22, 2024 | 248.53 |
February 21, 2024 | 228.24 |
February 20, 2024 | 229.71 |
February 16, 2024 | 233.13 |
February 15, 2024 | 222.22 |
February 14, 2024 | 217.98 |
February 13, 2024 | 204.80 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
55.89
Minimum
Jan 27 2022
312.00
Maximum
Apr 28 2023
130.19
Average
104.09
Median
May 08 2019
Total Return Price Benchmarks
Eli Lilly and Co | 732.20 |
Viking Therapeutics Inc | 65.07 |
Akero Therapeutics Inc | 20.26 |
89bio Inc | 8.58 |
Geron Corp | 3.58 |